½ÃÀ庸°í¼­
»óǰÄÚµå
1514835

¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, ¿¬·É´ëº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° Àü¸Á(2022-2032³â)

Global Enteral Syringe Market Size study, by Type (Reusable, Disposable), by Age Group (Adults, Pediatrics), by End User (Hospitals, Ambulatory Surgical Centers, Homecare), and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀåÀº 2023³â ¾à 3¾ï 8,360¸¸ ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö 5.3% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æÀå¿ë ½Ã¸°Áö´Â ¾×ü ¾à¹°, ¿µ¾çÁ¦ ¶Ç´Â ¾×ü¸¦ °ø±Þ Æ©ºê¸¦ ÅëÇØ ¼ÒÈ­°ü¿¡ Á÷Á¢ Åõ¿©ÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ÁÖ»ç±â´Â Á¤È®ÇÑ ¿ë·® ÃøÁ¤, °æÀå ¿µ¾ç Æ©ºê¿ÍÀÇ È£È¯¼º, ¿ì¹ßÀû ÀÎ ºÐ¸® ¹× ´©ÃâÀ» ¹æÁöÇÏ´Â ¾ÈÀü ¸ÞÄ¿´ÏÁòÀ» °®Ãß°í ÀÖ½À´Ï´Ù. °æÀå¿ë ½Ã¸°Áö´Â ƯÈ÷ »ïÅ´ Àå¾Ö, ½Å°æ Àå¾Ö, À§Àå Àå¾Ö, ¼ö¼ú ÈÄ È¸º¹ µîÀÇ ÁúȯÀ¸·Î ÀÎÇØ ±¸°­À¸·Î À½½ÄÀ» »ïŰ°Å³ª ¼·ÃëÇÒ ¼ö ¾ø´Â ȯÀڵ鿡°Ô °æÀ念¾ç¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¿µ¾ç½ÇÁ¶ ¹ß»ý·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ÃËÁøÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

ºó°ï, ¿µ¾ç°¡ ³ôÀº ½Äǰ¿¡ ´ëÇÑ Á¢±Ù¼º ºÎÁ·, ¸¸¼ºÁúȯ, °í·ÉÈ­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¿µ¾ç½ÇÁ¶ »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó Çʼö ¿µ¾ç¼Ò¸¦ °ø±ÞÇÏ´Â °æÀå¿ë ½Ã¸°ÁöÀÇ Áß¿äÇÑ ¿ªÇÒÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¿À²ÀûÀÎ ¿µ¾ç °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â °æÀå¿ë ½Ã¸°Áö ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦°¡ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±âÁذú ½ÂÀÎ ÀýÂ÷¸¦ ÁؼöÇϱâ À§Çؼ­´Â ¸¹Àº ÅõÀÚ°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ Á¦Ç° ½ÂÀÎ ±â°£ÀÌ ±æ¾îÁö°í Á¦Á¶ ºñ¿ëÀÌ »ó½ÂÇÏ¿© ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾î·Á¿ò¿¡µµ ºÒ±¸Çϰí, ºÎÀÛ¿ëÀ» ÁÙÀΠ÷´Ü ¿µ¾ç°ø±ÞÀåÄ¡ÀÇ °³¹ßÀº À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ȯÀÚÀÇ Æí¾ÈÇÔ°ú Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇÑ °æÀå¿ë ½Ã¸°ÁöÀÇ µðÀÚÀÎ, Àç·á ¹× ±â´ÉÀÇ Çõ½ÅÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì, ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â °æÀå¿ë ½Ã¸°Áö ½ÃÀå¿¡¼­ ¼öÀÍ Ãø¸é¿¡¼­ Áö¹èÀûÀÎ Áö¿ªÀÔ´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀº Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ¸¸¼º Áúȯ À¯º´·ü, À¯¸®ÇÑ »óȯ Á¤Ã¥ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ÇコÄɾî ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ °³¼±, À念¾ç¿ä¹ý¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á ÅõÀÚ Áõ°¡ µîÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ÁÖ¿ä ¿ä¾à

  • ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022³â-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • À¯Çüº°
    • ¿¬·ÉÃþº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦2Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ »çÇ× ¹× Á¦¿Ü »çÇ×
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼ú Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ]
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ±âȸ

      Á¦4Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå »ê¾÷ ºÐ¼®

      • Porter's Five Forces ¸ðµ¨
        • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
        • ¹ÙÀ̾îÀÇ ±³¼··Â
        • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
        • ´ëüǰÀÇ À§Çù
        • °æÀï ±â¾÷°£ °æÀï °ü°è
        • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
        • Porter's Five ForcesÀÇ ¿µÇ⠺м®
      • PESTEL ºÐ¼®
        • Á¤Ä¡
        • °æÁ¦
        • »çȸ
        • ±â¼ú
        • ȯ°æ
        • ¹ý·ü
      • ÁÖ¿ä ÅõÀÚ ±âȸ
      • ÁÖ¿ä ¼º°ø Àü·«
      • ÆÄ±«Àû µ¿Çâ
      • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
      • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

      Á¦5Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°(2022³â-2032³â)

      • ºÎ¹® ´ë½Ãº¸µå
      • ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : À¯Çüº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
        • ÀçÀÌ¿ë °¡´É
        • ÀÏȸ¿ë À¯Çü

      Á¦6Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿¬·ÉÃþº°(2022³â-2032³â)

      • ºÎ¹® ´ë½Ãº¸µå
      • ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : ¿¬·ÉÃþº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
        • ¼ºÀÎ
        • ¼Ò¾Æ°ú

      Á¦7Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(2022³â-2032³â)

      • ºÎ¹® ´ë½Ãº¸µå
      • ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
        • º´¿ø
        • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
        • ÀçÅÃÄ¡·á

      Á¦8Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022³â-2032³â)

      • ºÏ¹Ì °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ¹Ì±¹ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
          • À¯Çüº°
          • ¿¬·ÉÃþº°
          • ÃÖÁ¾»ç¿ëÀÚº°
        • ij³ª´Ù °æÀå¿ë ½Ã¸°Áö ½ÃÀå
      • À¯·´ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ¿µ±¹ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • µ¶ÀÏ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ÇÁ¶û½º °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ½ºÆäÀÎ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ÀÌÅ»¸®¾Æ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ±âŸ À¯·´ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
      • ¾Æ½Ã¾ÆÅÂÆò¾ç °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • Áß±¹ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • Àεµ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ÀϺ» °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • È£ÁÖ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • Çѱ¹ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç °æÀå¿ë ½Ã¸°Áö ½ÃÀå
      • ¶óƾ¾Æ¸Þ¸®Ä« °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ºê¶óÁú °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ¸ß½ÃÄÚ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« °æÀå¿ë ½Ã¸°Áö ½ÃÀå
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • »ç¿ìµð¾Æ¶óºñ¾Æ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
        • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« °æÀå¿ë ½Ã¸°Áö ½ÃÀå

      Á¦9Àå °æÀï Á¤º¸

      • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
      • ÁÖ¿ä ½ÃÀå Àü·«
      • ±â¾÷ °³¿ä
        • Fresenius SE & Co. KGaA
          • ÁÖ¿ä Á¤º¸
          • °³¿ä
          • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
          • Á¦Ç° °³¿ä
          • ½ÃÀå Àü·«
        • Boston Scientific Corporation
        • Danone
        • Cook Medical, Inc.
        • Cardinal Health Inc.
        • Becton, Dickinson and Company
        • Moog Inc.
        • B. Braun Melsungen AG
        • Owens & Minor, Inc.
        • Nestle S.A.
        • Medtronic PLC
        • Medline Industries LP
        • Kentec Medical Inc.
        • Thermo Fisher Scientific Inc
        • Baxter International Inc.

      Á¦10Àå Á¶»ç °úÁ¤

      • Á¶»ç °úÁ¤
        • µ¥ÀÌÅÍ ¸¶ÀÌ´×
        • ºÐ¼®
        • ½ÃÀå ÃßÁ¤
        • °ËÁõ
        • ÃâÆÇ
      • Á¶»ç ¼Ó¼º
      LSH 24.07.24

      Global Enteral Syringe Market is valued at approximately USD 383.6 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2024-2032. Enteral syringes are specialized medical devices used to administer liquid medications, nutrients, or fluids directly into the gastrointestinal tract through a feeding tube. These syringes feature accurate volume measurements, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage. Enteral syringes are essential in enteral nutrition, particularly for patients unable to swallow or consume food orally due to conditions like dysphagia, neurological disorders, gastrointestinal disorders, or recovery from surgery. The increasing incidence of malnutrition serves as a significant driver for market growth.

      The global rise in malnutrition cases, driven by factors such as poverty, inadequate access to nutritious food, chronic illnesses, and aging populations, underscores the critical role of enteral syringes in delivering essential nutrients. This rising need for efficient nutrition management propels the demand for enteral syringes. However, stringent governmental regulations impose challenges on market growth. Compliance with strict standards and approval processes requires significant investments, leading to prolonged product approval timelines and increased manufacturing costs, which can hinder market expansion. Despite these challenges, the development of advanced feeding devices with reduced side effects presents lucrative opportunities. Innovations in enteral syringe design, materials, and functionalities, aimed at enhancing patient comfort and treatment outcomes, are expected to drive market growth during the forecast period.

      The key regions considered for the global enteral syringe market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the enteral syringe market in terms of revenue. The market growth in the region is being attributed to factors including well-established healthcare infrastructure, high prevalence of chronic diseases, and favorable reimbursement policies. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rapid improvements in healthcare infrastructure, increased awareness about enteral nutrition therapy, and rising healthcare investments.

      Major market player included in this report are:

      • Fresenius SE & Co. KGaA
      • Boston Scientific Corporation
      • Danone
      • Cook Medical, Inc.
      • Cardinal Health Inc.
      • Becton, Dickinson and Company
      • Moog Inc.
      • B. Braun Melsungen AG
      • Owens & Minor, Inc.
      • Nestle S.A.
      • Medtronic PLC
      • Medline Industries LP
      • Kentec Medical Inc.
      • Thermo Fisher Scientific Inc.
      • Baxter International Inc.

      The detailed segments and sub-segment of the market are explained below:

      By Type

      • Reusable
      • Disposable

      By Age Group

      • Adults
      • Pediatrics

      By End User

      • Hospitals
      • Ambulatory Surgical Centers
      • Homecare

      By Region:

      • North America
      • U.S.
      • Canada
      • Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • ROE
      • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • RoAPAC
      • Latin America
      • Brazil
      • Mexico
      • RoLA
      • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • RoMEA

      Years considered for the study are as follows:

      • Historical year - 2022
      • Base year - 2023
      • Forecast period - 2024 to 2032

      Key Takeaways:

      • Market Estimates & Forecast for 10 years from 2022 to 2032.
      • Annualized revenues and regional level analysis for each market segment.
      • Detailed analysis of geographical landscape with Country level analysis of major regions.
      • Competitive landscape with information on major players in the market.
      • Analysis of key business strategies and recommendations on future market approach.
      • Analysis of competitive structure of the market.
      • Demand side and supply side analysis of the market.

      Table of Contents

      Chapter 1. Global Enteral Syringe Market Executive Summary

      • 1.1. Global Enteral Syringe Market Size & Forecast (2022-2032)
      • 1.2. Regional Summary
      • 1.3. Segmental Summary
        • 1.3.1. By Type
        • 1.3.2. By Age Group
        • 1.3.3. By End User
      • 1.4. Key Trends
      • 1.5. Recession Impact
      • 1.6. Analyst Recommendation & Conclusion

      Chapter 2. Global Enteral Syringe Market Definition and Research Assumptions

      • 2.1. Research Objective
      • 2.2. Market Definition
      • 2.3. Research Assumptions
        • 2.3.1. Inclusion & Exclusion
        • 2.3.2. Limitations
        • 2.3.3. Supply Side Analysis
          • 2.3.3.1. Availability
          • 2.3.3.2. Infrastructure
          • 2.3.3.3. Regulatory Environment
          • 2.3.3.4. Market Competition
          • 2.3.3.5. Economic Viability (Consumer's Perspective)
        • 2.3.4. Demand Side Analysis
          • 2.3.4.1. Regulatory frameworks
          • 2.3.4.2. Technological Advancements
          • 2.3.4.3. Environmental Considerations
          • 2.3.4.4. Consumer Awareness & Acceptance
      • 2.4. Estimation Methodology
      • 2.5. Years Considered for the Study
      • 2.6. Currency Conversion Rates

      Chapter 3. Global Enteral Syringe Market Dynamics

      • 3.1. Market Drivers
        • 3.1.1. Rising Incidence of Malnutrition
        • 3.1.2. Growing Prevalence of Chronic Diseases
        • 3.1.3. Increasing Demand for Enteral Nutrition
      • 3.2. Market Challenges
        • 3.2.1. Stringent Governmental Regulations
        • 3.2.2. High Production and Compliance Costs
      • 3.3. Market Opportunities
        • 3.3.1. Development of Advanced Feeding Devices
        • 3.3.2. Innovations in Enteral Syringe Design
        • 3.3.3. Expansion into Emerging Markets

      Chapter 4. Global Enteral Syringe Market Industry Analysis

      • 4.1. Porter's 5 Force Model
        • 4.1.1. Bargaining Power of Suppliers
        • 4.1.2. Bargaining Power of Buyers
        • 4.1.3. Threat of New Entrants
        • 4.1.4. Threat of Substitutes
        • 4.1.5. Competitive Rivalry
        • 4.1.6. Futuristic Approach to Porter's 5 Force Model
        • 4.1.7. Porter's 5 Force Impact Analysis
      • 4.2. PESTEL Analysis
        • 4.2.1. Political
        • 4.2.2. Economical
        • 4.2.3. Social
        • 4.2.4. Technological
        • 4.2.5. Environmental
        • 4.2.6. Legal
      • 4.3. Top investment opportunity
      • 4.4. Top winning strategies
      • 4.5. Disruptive Trends
      • 4.6. Industry Expert Perspective
      • 4.7. Analyst Recommendation & Conclusion

      Chapter 5. Global Enteral Syringe Market Size & Forecasts by Type (2022-2032)

      • 5.1. Segment Dashboard
      • 5.2. Global Enteral Syringe Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
        • 5.2.1. Reusable
        • 5.2.2. Disposable

      Chapter 6. Global Enteral Syringe Market Size & Forecasts by Age Group (2022-2032)

      • 6.1. Segment Dashboard
      • 6.2. Global Enteral Syringe Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Million)
        • 6.2.1. Adults
        • 6.2.2. Pediatrics

      Chapter 7. Global Enteral Syringe Market Size & Forecasts by End User (2022-2032)

      • 7.1. Segment Dashboard
      • 7.2. Global Enteral Syringe Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
        • 7.2.1. Hospitals
        • 7.2.2. Ambulatory Surgical Centers
        • 7.2.3. Homecare

      Chapter 8. Global Enteral Syringe Market Size & Forecasts by Region (2022-2032)

      • 8.1. North America Enteral Syringe Market
        • 8.1.1. U.S. Enteral Syringe Market
          • 8.1.1.1. By Type
          • 8.1.1.2. By Age Group
          • 8.1.1.3. By End User
        • 8.1.2. Canada Enteral Syringe Market
      • 8.2. Europe Enteral Syringe Market
        • 8.2.1. UK Enteral Syringe Market
        • 8.2.2. Germany Enteral Syringe Market
        • 8.2.3. France Enteral Syringe Market
        • 8.2.4. Spain Enteral Syringe Market
        • 8.2.5. Italy Enteral Syringe Market
        • 8.2.6. Rest of Europe Enteral Syringe Market
      • 8.3. Asia-Pacific Enteral Syringe Market
        • 8.3.1. China Enteral Syringe Market
        • 8.3.2. India Enteral Syringe Market
        • 8.3.3. Japan Enteral Syringe Market
        • 8.3.4. Australia Enteral Syringe Market
        • 8.3.5. South Korea Enteral Syringe Market
        • 8.3.6. Rest of Asia Pacific Enteral Syringe Market
      • 8.4. Latin America Enteral Syringe Market
        • 8.4.1. Brazil Enteral Syringe Market
        • 8.4.2. Mexico Enteral Syringe Market
        • 8.4.3. Rest of Latin America Enteral Syringe Market
      • 8.5. Middle East & Africa Enteral Syringe Market
        • 8.5.1. Saudi Arabia Enteral Syringe Market
        • 8.5.2. South Africa Enteral Syringe Market
        • 8.5.3. Rest of Middle East & Africa Enteral Syringe Market

      Chapter 9. Competitive Intelligence

      • 9.1. Key Company SWOT Analysis
      • 9.2. Top Market Strategies
      • 9.3. Company Profiles
        • 9.3.1. Fresenius SE & Co. KGaA
          • 9.3.1.1. Key Information
          • 9.3.1.2. Overview
          • 9.3.1.3. Financial (Subject to Data Availability)
          • 9.3.1.4. Product Summary
          • 9.3.1.5. Market Strategies
        • 9.3.2. Boston Scientific Corporation
        • 9.3.3. Danone
        • 9.3.4. Cook Medical, Inc.
        • 9.3.5. Cardinal Health Inc.
        • 9.3.6. Becton, Dickinson and Company
        • 9.3.7. Moog Inc.
        • 9.3.8. B. Braun Melsungen AG
        • 9.3.9. Owens & Minor, Inc.
        • 9.3.10. Nestle S.A.
        • 9.3.11. Medtronic PLC
        • 9.3.12. Medline Industries LP
        • 9.3.13. Kentec Medical Inc.
        • 9.3.14. Thermo Fisher Scientific Inc
        • 9.3.15. Baxter International Inc.

      Chapter 10. Research Process

      • 10.1. Research Process
        • 10.1.1. Data Mining
        • 10.1.2. Analysis
        • 10.1.3. Market Estimation
        • 10.1.4. Validation
        • 10.1.5. Publishing
      • 10.2. Research Attributes
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦